跳至主要内容
临床试验/ISRCTN18006597
ISRCTN18006597
已完成
未知

Investigating the Effects of Sleep Restriction Therapy for Insomnia on Circadian Timing

niversity of Oxford0 个研究点目标入组 18 人2019年3月15日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
niversity of Oxford
入组人数
18
状态
已完成
最后更新
5年前

概览

简要总结

2020 results in https://doi.org/10.1111/jsr.13260 (added 01/02/2021)

注册库
who.int
开始日期
2019年3月15日
结束日期
2020年1月1日
最后更新
5年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 1\. Participant is willing and able to give informed consent for participation in the study.
  • 2\. Male or Female, aged 25\-55 years
  • 3\. Screen positive for persistent insomnia (chronicity \>3 months) as indicated on the Sleep Condition Indicator and meet DSM\-5 criteria for insomnia disorder
  • 4\. Sleep efficiency \< 85%
  • 5\. Intermediate chronotype as indicated by the Morningness\-Eveningness questionnaire (score between 31 and 69\)
  • 6\. Participant is able to comply with study procedures
  • 7\. Body mass index between 18 and 30 kg/m2

排除标准

  • 1\. Clinically significant anxiety or depressive symptoms (Anxiety (HADS) \> 10\)
  • 2\. Psychiatric diagnoses other than insomnia
  • 3\. Previous or current engagement with psychological treatment for insomnia (by healthcare professional or online)
  • 4\. Additional sleep disorder diagnosis or positive screen (e.g. Narcolepsy, circadian rhythm disorder)
  • 5\. Sleep\-disruptive medical comorbidity or conditions contraindicated for SRT (e.g. epilepsy)
  • 6\. Current prescription of CNS or hormonal medication
  • 7\. Overnight, early morning, evening, or rotating shift work in the last 3 months
  • 8\. Pregnancy, lactation, perimenopausal or menopausal
  • 9\. Travelled across more than 2 time zones in the prior 3 months
  • 10\. Smoked more than 5 cigarettes/week in the previous 3 months

结局指标

主要结局

未指定

相似试验